| 1 |
32980960 | MET canonical transcript expression is a predictive biomarker for chemo-sensitivity to MET-inhibitors in hepatocellular carcinoma cell lines. | 2021 Jan |
4 |
| 2 |
33497758 | Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer. | 2021 Apr |
1 |
| 3 |
34164713 | Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors. | 2021 Oct |
1 |
| 4 |
34804015 | Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib? | 2021 |
2 |
| 5 |
32716114 | A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinoma. | 2020 Oct |
3 |